T0	Outcomes 26 42	pharmacokinetics
T1	Outcomes 977 1117	relative bioavailability of morphine and naltrexone when MS-sNT is administered (under fasting conditions) with increasing doses of alcohol.
T2	Outcomes 1249 1265	drug interaction
T3	Outcomes 1373 1398	overall morphine exposure
T4	Outcomes 1444 1450	C(max)
T5	Outcomes 1468 1474	t(max)
T6	Outcomes 1525 1563	Naltrexone sequestering was successful